Back EuCorVac-19 Arabic ইউকোরভ্যাক-১৯ Bengali/Bangla EuCorVac-19 Czech EuCorVac-19 Greek EuCorVac-19 Korean EuCorVac-19 NB ЕуКорВак-19 Serbian Eucorvac-19 Swedish EuCorVac-19 Ukrainian
| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Protein subunit |
| Clinical data | |
| Routes of administration | Intramuscular |
EuCorVac-19 is a COVID-19 vaccine candidate developed by EuBiologics Co.[1][2][3][4]
- ^ "EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea". Business Wire. 21 January 2021. Retrieved 17 April 2021.
- ^ Moon-hee C (21 January 2021). "EuBiologics Wins Approval on Clinical Trial of COVID-19 Vaccine 'EuCOVAC-19'". Business Korea. Retrieved 17 April 2021.
- ^ "EuBiologics Gets an IND Approval for Phase I/II Clinical Trial of 'EuCorVac-19' in Korea". EuBiologics. 21 January 2021. Retrieved 17 April 2021.
- ^ "Firm looks to build vaccine manufacturing plant in PH". ABS-CBN News. 12 April 2021. Retrieved 17 April 2021.
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search